AECOM heads into its August 10 earnings with a compelling tension: management has been buying shares near current prices while options traders have turned the most defensively positioned they have been all year.
The insider signal is the most concrete data point on the board right now. CEO Troy Rudd and CFO Gaurav Kapoor both bought shares in May at around $71, shortly after the stock fell sharply on Q2 results. President Lara Poloni added another $298,000 in mid-June at $70.63. Net insider buying over the past 90 days totals just under $700,000 — a meaningful cluster of C-suite conviction at prices close to where the stock trades today at $68.94. The timing is notable: these purchases came after the stock had already shed roughly 30% from its December highs near $98, where the same executives were sellers. The pattern is straightforward — they sold into strength and are now buying into weakness.
Options traders are reading the setup differently. The put/call ratio has jumped to 0.74, more than two standard deviations above its 20-day average of 0.58 — the highest defensive reading of the past year. Monday's reading briefly touched the 52-week peak of 0.77 before easing slightly. That kind of hedging pressure, this close to an earnings date three weeks out, suggests the market remembers what happened last time: ACM fell roughly 13% the day after its May print and was still down more than 11% five days later. The options market is clearly pricing in the possibility of a repeat.
Short interest tells a less alarming story than the options skew implies. At 6.3% of free float — up 28% over the past month — shorts have been rebuilding meaningfully since early July, when the position jumped from around 6.1 million shares to above 8.2 million in a matter of days. That is a genuine move worth tracking. Yet the borrow market remains entirely unconstrained: availability is at roughly 4,400% of current short interest, meaning lenders have vastly more stock to offer than shorts currently want. Borrowing costs are low at 0.44% annually. This is not a squeeze setup — it is a measured short rebuild into an event, with plenty of room to grow if the thesis develops.
The Street remains constructive on the name but has been steadily trimming targets. RBC Capital lowered its target to $105 this week while holding its Outperform rating. Truist and Citi have both cut targets in recent months, though all three retain bullish ratings. The consensus target of $99.29 implies roughly 44% upside from current prices — a gap that reflects genuine disagreement about the path back rather than a wholesale re-rating. Bull case arguments centre on AECOM's defense exposure, its ambition to double net service revenue by 2028, and the early returns from AI-assisted contract wins. Bears point to slower government funding flows, project claims risk, and the overhang of international exposure. The 12-month forward EPS growth trajectory has swung sharply positive — from deeply negative in January to a large positive by mid-year — but the price-to-earnings multiple at 10.8x remains subdued, reflecting lingering skepticism about execution.
The August 10 print is therefore less about whether AECOM is structurally sound and more about whether management can credibly reset the growth narrative after a bruising spring — and whether the insider buyers closer to $70 prove to have timed it well.
See the live data behind this article on ORTEX.
Open ACM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
